Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model

A. Gazdhar, M. Hofmann, T. Krause, R. A. Schmid, T. Geiser (Bern, Switzerland)

Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Session: New modalities and application in imaging of the chest
Session type: Oral Presentation
Number: 3563
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Gazdhar, M. Hofmann, T. Krause, R. A. Schmid, T. Geiser (Bern, Switzerland). Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model. Eur Respir J 2006; 28: Suppl. 50, 3563

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009



Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013


Molecular imaging of the progression of pulmonary fibrosis using animal models of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 605s
Year: 2006

Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study
Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
Year: 2021



Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


The immunomodulatory effect of protein S in pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013


Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Animal models of pulmonary emphysema: a stereologist's perspective
Source: Eur Respir Rev 2006; 15: 136-147
Year: 2006



Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Year: 2018

Longitudinal assessment of lung fibrosis by micro CT correlates with histological evaluation in bleomycin-induced mice
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016


Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


PBI-compound, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: A comparative study with pirfenidone
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013


The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017


Use of MRI for functional and structural assessment of interstitial lung disease
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018


The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Use of pulmonary proteomics to investigate lung disease
Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease
Year: 2004

Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Source: International Congress 2015 – New insights into IIPs
Year: 2015